DIN 02469332 — CUVPOSA 1 MG
CUVPOSA is a solution of Glycopyrrolate marketed by MEDEXUS PHARMACEUTICALS INC.. The full Glycopyrrolate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02469332
- Brand name
- CUVPOSA
- Active ingredient
- Glycopyrrolate
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- ORAL
- Manufacturer
- MEDEXUS PHARMACEUTICALS INC.
- Health Canada status
- MARKETED
- Drug class
- Anticholinergic (antimuscarinic) agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Glycopyrrolate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02382857 | GLYCOPYRROLATE INJECTION | 0.2 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED |
| 02382849 | GLYCOPYRROLATE INJECTION MULTIDOSE | 0.2 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02039508 | GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02473879 | GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02513749 | GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02532379 | GLYCOPYRROLATE INJECTION USP | 0.2 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02473895 | GLYCOPYRROLATE INJECTION USP | 0.4 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02473887 | GLYCOPYRROLATE INJECTION USP | 4 MG | SOLUTION | STERIMAX INC | MARKETED |